Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PLASMALOGEN COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR TREATING DISEASES CAUSED BY AGING
Document Type and Number:
Japanese Patent JP2015145388
Kind Code:
A
Abstract:
PROBLEM TO BE SOLVED: To provide compounds which, when administered to mammalian biological systems, result in increased cellular concentrations of specific sn-2 substituted ethanolamine plasmalogens independent of the ether lipid synthesis capacity of the system thereby causing lowering of membrane cholesterol levels and lowering of amyloid secretion, and can be used for the treatment or prevention of diseases caused by aging.SOLUTION: The present invention provides 1-alkyl, 2-acyl glycerol derivatives represented by compound PPI-1009, and pharmaceutical compositions.

Inventors:
M AMIN KHAN
PAUL L WOOD
DAYAN GOODENOWE
RISHIKESH MANKIDY
PEARSON AHIAHONU
Application Number:
JP2015052549A
Publication Date:
August 13, 2015
Filing Date:
March 16, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
PHENOMENOME DISCOVERIES INC
International Classes:
C07C229/22; A61K31/232; A61K31/385; A61P3/06; A61P9/00; A61P9/10; A61P25/16; A61P25/28; A61P27/02; A61P35/00; C07C69/587; C07C323/59; C07D339/04
Domestic Patent References:
JP2007531706A2007-11-08
JP2008125365A2008-06-05
Foreign References:
WO2008093709A12008-08-07
US20080021000A12008-01-24
Other References:
JPN6015052811; Goodenowe, Dayan B.; Cook, Lisa L.; Liu, Jun; Lu, Yingshen; Jayasinghe,     Dushmanthi A.; Ahiahonu,: 'Peripheral ethanolamine plasmalogen deficiency: a logical causative factor     in Alzheimer's diseas' Journal of Lipid Research 48(11), 2007, 2485-2498
JPN6015052814; Han, Xianlin; Holtzman, David M.; McKee, Daniel W., Jr.: 'Plasmalogen deficiency in early Alzheimer's disease subjects and in     animal models: molecular cha' Journal of Neurochemistry 77(4), 2001, 1168-1180
JPN6015052815; Gorgas, Karin et al.: 'The ether lipid-deficient mouse: Tracking down plasmalogen functins' Biochimica et Biophysica Acta 1763, 2006, 1511-1526
JPN6015052819; Igbavboa, Urule; Hamilton, Jillonne; Kim, Hee-Yong; Sun, Grace Y.; Wood,     W. Gibson: 'A new role for apolipoprotein E: modulating transport of polyunsaturated     phospholipid molecular' Journal of Neurochemistry 80(2), 2002, 255-261
JPN6015052821; Han, Xianlin; Abendschein, Dana R.; Kelley, John G.; Gross, Richard W.: 'Diabetes-induced changes in specific lipid molecular species in rat     myocardium' Biochemical Journal 352(1), 2000, 79-89
JPN6015052823; Lohmeyer, M.; Workman, P.: 'Growth arrest vs. direct cytotoxicity and the importance of molecular     structure for the in vitro' British Journal of Cancer 72(2), 1995, 277-86
JPN6015052826; Andresen, Thomas L.; Davidsen, Jesper; Begtrup, Mikael; Mouritsen, Ole G.;     Jorgensen, Kent: 'Enzymatic Release of Antitumor Ether Lipids by Specific Phospholipase A2     Activation of Liposome-' Journal of Medicinal Chemistry 47(7), 2004, 1694-1703
JPN6014003797; Tetrahedron:Asymmetry 8(18), 1997, p.3131-3142
Attorney, Agent or Firm:
Masaki Hirota
Seiji Ozawa
Yusaku Tokai
Kazuhiro Matsuda
Makoto Horiuchi
Masako Yamauchi
Shohei Fujimoto
Shuichi Sonomoto
Akihiro Yamamura



 
Previous Patent: SOLID COMPOSITIONS

Next Patent: METHODS FOR TREATING PSORIASIS